MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
Enliven Therapeutics, Inc. Common Stock

ELVN

#1719
Enliven Therapeutics, Inc. Common Stock
29.6900
+2.63%
Sector:
Base:
Profit Currency:
Daily Range
29.6900
29.7000
Year Range
14.7850
29.9800
Daily Change
+2.63%
Monthly Change
+13.58%
6 month change
+43.71%
Year Change
+43.71%
Previous Close
28.9300
Open
29.7000
Bid
Ask
Low
29.6900
High
29.7000
Volume
140
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. ELVN
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

News

Investing Investing
ELVN
2026.02.19
Heyman, direttore di Enliven Therapeutics, vende azioni per 32.000$
Investing Investing
ELVN
2026.02.19
Heyman, Enliven Therapeutics director, sells $32k in stock
Investing Investing
ELVN
2026.02.10
Lyssikatos, CSO di Enliven Therapeutics, vende azioni per $145k
Investing Investing
ELVN
2026.02.10
Lyssikatos, Enliven Therapeutics CSO, sells $145k in shares
Investing Investing
ELVN TERN
2026.01.22
Lyssikatos, CSO di Enliven Therapeutics, vende azioni ELVN per 535.000$
Investing Investing
ELVN TERN
2026.01.22
Lyssikatos, Enliven Therapeutics CSO, sells $535k in ELVN stock
Investing Investing
ELVN
2026.01.22
Il direttore di Enliven Therapeutics Heyman vende azioni per $32.901
Investing Investing
ELVN
2026.01.22
Enliven Therapeutics director Heyman sells $32,901 in stock
Investing Investing
ELVN
2026.01.13
Anish Patel, COO of Enliven Therapeutics, sells $1.35m in ELVN
Seeking Alpha Seeking Alpha
ELVN
2026.01.13
Enliven Therapeutics: Springing Into 2026 With Data, But I'm Still Cautious
Investing Investing
ELVN
2026.01.12
Il CSO di Enliven Therapeutics Lyssikatos vende azioni per 3,47 milioni di dollari
Investing Investing
ELVN
2026.01.12
Enliven Therapeutics CSO Lyssikatos sells $3.47 million in shares

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd